Windtree Therapeutics Inc (NAS:WINT)
$ 0.2552 -0.0137 (-5.09%) Market Cap: 2.29 Mil Enterprise Value: 2.01 Mil PE Ratio: 0 PB Ratio: 0.14 GF Score: 22/100

Windtree Therapeutics Inc at Ladenburg Thalmann R&D Showcase Transcript

Dec 09, 2020 / NTS GMT
Release Date Price: $5346 (-3.57%)
Destiny Hance
Ladenburg Thalmann & Co. Inc - Moderator

Hello, and welcome to the Ladenburg Thalmann R&D Showcase. Our showcase is designed to highlight companies working through the development, clinical, and regulatory processes. Today, we are excited to showcase Windtree Therapeutics, and we'll turn it over to management in a moment.

We would first like to bring your attention to our necessary disclosures. Further, we would like to reiterate this webinar is being recorded. For any questions or concerns, please contact me, Destiny Hance at [email protected]. Without further ado, I would like to hand the floor over to Jeffrey Cohen, Managing Director, Equity Research. Jeff?

Jeffrey Cohen
Ladenburg Thalmann & Co. Inc. - Analyst

Thanks Destiny, and thanks everyone for joining us. Today, we have the management team of Windtree Therapeutics on who's going to be going through their pipeline, which is quite robust and diversified today with you. So thank you for joining us. I'm going to introduce the three management members and then let them

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot